Biotage appoints Nomination Committee


A Nomination Committee consisting of shareholder representatives and the
Chairman of the Board of Directors has been formed for Biotage AB. The
Nomination Committee shall, before the Annual General Meeting 2016, prepare
proposal for the election of Chairman and other members of the Board of
Directors, the election of Chairman of the Annual Meeting, election of Auditors,
the determination of fees and matters pertaining thereto.

The members of the Nominations Committee are:
Ove Mattsson, Chairman of the Board, holding by endowment insurances
Anders Walldov, Brohuvudet AB and direct holding
Thomas Ehlin, Fjärde AP-fonden
Andreas Bladh, Varenne AB

Shareholders wishing to submit a proposal for members of the Board of Directors
may do so by sending e-mail to the Chairman of the Board of Directors of Biotage
AB at: info@biotage.com

The Annual General Meeting 2016 in Biotage will be held on Thursday, April 28,
2016 at 4:00pm CET in Uppsala. Shareholders who want to have a matter addressed
at the Annual General Meeting 2016 must submit such a proposal to the same
address as above (subject “Annual General Meeting 2016” for the e-mail and the
letter, respectively) seven weeks in advance of the meeting at the latest.


Kontaktperson:
Ove Mattsson, Chairman of the Board
Tel: 0733-727280, ove.mattsson@swipnet.se

 (ove.mattsson@swipnet.se)

Biotage discloses the information provided herein pursuant to the Swedish
Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The
information was submitted for publication at 10.00 on 20 October 2015.

About Biotage
Biotage offers efficient separation technologies from analysis to industrial
scale and high quality solutions for analytical chemistry from research to
commercial analysis laboratories. Biotage’s products are used by government
authorities, academic institutions, pharmaceutical and food companies, among
others. The company is headquartered in Uppsala and has offices in the US, UK,
China and Japan. Biotage has approx. 290 employees and had sales of 490 MSEK in
2014. Biotage is listed on the NASDAQ OMX Stockholm stock exchange. Website:
www.biotage.com

Attachments

10200605.pdf